Compare CGAU & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGAU | MMS |
|---|---|---|
| Founded | 2002 | 1975 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Business Services |
| Sector | Basic Materials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.6B |
| IPO Year | 2021 | 1997 |
| Metric | CGAU | MMS |
|---|---|---|
| Price | $19.68 | $69.64 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 640.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | 1.05% | ★ 1.90% |
| EPS Growth | N/A | ★ 10.42 |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | ★ $2,392,236,000.00 |
| Revenue This Year | $24.44 | $0.44 |
| Revenue Next Year | $12.88 | $5.15 |
| P/E Ratio | ★ $11.74 | $40.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.31 | $60.75 |
| 52 Week High | $21.17 | $100.00 |
| Indicator | CGAU | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 61.26 | 52.49 |
| Support Level | $17.51 | $60.75 |
| Resistance Level | $20.15 | $89.28 |
| Average True Range (ATR) | 0.74 | 2.02 |
| MACD | 0.24 | 1.04 |
| Stochastic Oscillator | 88.41 | 87.84 |
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.